- ZEVASKYN, the first and only cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), now commercially available in the U.S. - - Ann & Robert H. Lurie Children's Hospital of Chicago, a top-ranked hospital, is ready to evaluate patients for ZEVASKYN treatment - - Abeona Assist™ comprehensive patient services program in place to offer personalized support for eligible patients and their families throughout ZEVASKYN treatment journey - CLEVELAND and CHICAGO, May 14, 2025 ( ...

Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still expected to readout in third quarter of 2025Data presented at recent congresses reinforces the potential of the company’s T-Win candidates to reshape the tumor microenvironment and drive more effective anti-tumor responsesCompany recognized as one of the most innovative biotechnology companies in the world by Fast Company Company to participate in TD Cowen’s ...

BOCA RATON, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (“DeFi Dev Corp” or the “Company”), a public-market vehicle focused on long-term Solana (“SOL”) accumulation, today announced financial results for the first quarter ended March 31, 2025, and provided a strategic update on recent treasury activity. Q1 2025 Financial Highlights: 379% year-over-year improvement in annual recurring revenue related to SaaS businessSaaS revenue of approximately $191,000, up 163% year-over-ye ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published comparative study of single-use Negative Pressure Wound Therapy (sNPWT) devices in Caesarean section (C-section) recovery has identified significant benefits for postpartum use of Smith+Nephew’s leading PICO sNPWT technology. Analyzing real-world data from over 10,000 C-section patients treated at different pressure levels, the study published in WOUNDS (April 2025) reveals that PICO sNPWT ...

-- New data showed setmelanotide achieved consistent, meaningful weight reduction -- -- Multiple presentations delivered at the first-ever Joint Congress between the European Society for Paediatric Endocrinology and the European Society of Endocrinology (ESPE-ESE); 32nd annual European Congress on Obesity (ECO); and the 2025 annual meeting of the Pediatric Endocrine Society (PES 2025) -- BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharm ...

文章核心观点 - LEEF Brands与Glass House Brands达成管理服务协议，Glass House将管理LEEF的棕榈沙漠药房，双方可实现优势互补共同发展 [1][2][3] 合作协议内容 - LEEF与Glass House签订管理服务协议，Glass House获独家权利管理棕榈沙漠药房一年，有延期可能 [1][2] - Glass House承担药房日常管理职责，还与LEEF达成承购协议，保障LEEF提取生产线所需原料 [3] 双方表态 - Glass House联合创始人表示合作可扩大其在棕榈泉市场零售和批发业务，体现其在加州市场实力，零售团队同店销售额连续五季度年化增长，上季度零售收入增长超加州市场30% [4] - LEEF首席执行官称合作提升药房水平，保障供应链需求，使LEEF专注核心业务，加强生产能力并为战略伙伴关系奠定基础 [4] 公司介绍 - LEEF是加州领先的大麻提取和制造公司，供应链完善、制造工艺先进、产品组合丰富 [5] - Glass House是美国增长最快的垂直整合大麻公司，专注加州市场，致力于打造品牌服务消费者，业务涵盖种植、制造、零售等环节 [6]

LONG BEACH, Calif. and TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF) – one of the fastest-growing, vertically integrated cannabis companies in the United States, and LEEF Brands, Inc. (CSE: LEEF) (OTCQB: LEEEF), one of California’s premier vertical extraction companies, today announced a Management Services Agreement (“MSA”). Under the MSA, Glass House will manage operation of LEEF’s Pa ...

DUBAI, United Arab Emirates, May 14, 2025 (GLOBE NEWSWIRE) -- Telesat (NASDAQ and TSX: TSAT), one of the world’s largest and most innovative satellite operators, and Arab Satellite Communications Organization (Arabsat), the top satellite service provider in the Arab world, today announced the companies have successfully negotiated and signed a Term Sheet for a multi-Gbps capacity pool of Telesat Lightspeed connectivity services. The companies executed the agreement today during a signing ceremony at the CAB ...

First quarter 2025 GAAP net income of $4.1 million or $0.18 per basic weighted average common share and Distributable Earnings(1)  of $4.5 million or $0.21 per basic weighted average common share WEST PALM BEACH, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- Advanced Flower Capital Inc. (Nasdaq: AFCG) (“Advanced Flower Capital”, “AFC” or the “Company”) today announced its results for the quarter ended March 31, 2025. AFC reported generally accepted accounting principles (“GAAP”) net income of $4.1 million or $0.18 ...

GAITHERSBURG, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of its executive management team will participate in the following investor conferences: RBC Global Healthcare Conference (New York, New York)Fireside chat on Tuesday, May 20 at 3:35 pm ETVirtual attendees can participate via webcast Goldman Sachs Leveraged Finance Conference, May 29, 2025 (Dana Point, California) Benchmark’s 5th Annual Healthcare House Call Virtual Investor ConferencePres ...